# Current Runtime Status

Date: 2026-05-31

## Executive Status

The local runtime checkpoint is stable and buildable.

## Validated Green

- TypeScript check: PASS
- Production build: PASS
- Test suite: PASS, 15 suites / 132 tests
- Lint: PASS with pre-existing warnings only
- Next route collision: FIXED
- VIP Governance tests: PASS
- Pharmacy Phase 1 foundation and DB work: preserved; not modified by the latest routing fix

## Latest Stabilization Commits

- `d926747` - Checkpoint validated governance and runtime hardening
- `08df3d5` - Fix duplicate study subject route

## Route Stabilization

The duplicate Next route at `/studies/[studyId]/subjects/[subjectId]` was resolved.

Canonical subject chart:

- `/studies/[studyId]/subjects/[subjectId]`

Legacy runtime preview:

- `/studies/[studyId]/subjects/[subjectId]/runtime-preview`

## Security Audit Status

`npm audit --omit=dev` reports two moderate vulnerabilities from `postcss` bundled through `next`.

The available automated fix requires `npm audit fix --force` and would install `next@9.3.3`, a breaking downgrade from the current Next 16 runtime. This fix was intentionally not applied.

## Known Remaining Risks

- Lint warnings remain in existing UI/runtime files.
- `postcss` advisory remains pending an upstream-safe Next/PostCSS upgrade path.
- Supabase storage local health issue was previously observed after migrations; Pharmacy schema validation should continue to treat storage health separately from DB schema validity.

## Protected Boundaries

The latest stabilization did not modify:

- Pharmacy Phase 1 foundations
- Pharmacy migrations
- Visit Runtime foundations
- Consent, Training, or Delegation Runtime foundations
- Supabase schema

## Recommended Next Step

Push the current branch to GitHub and open a review PR before starting Pharmacy Dispensing Runtime Phase 2.
